GAMMAGARD LIQUID is proven to improve or
maintain muscle strength and reduce disability
in adults with MMN1

In the largest clinical trial in MMN to date,3
GAMMAGARD LIQUID [Immune Globulin Infusion (Human)] 10% was shown to1:

  • Treatment with GAMMAGARD LIQUID in adults with MMN improved functioning by effectively maintaining and improving muscle strength, and reducing disability, compared to placebo1

Formulated with your needs in mind

  • sucrose1
  • added sugars1
  • added sodium1
  • added preservatives1

The packaging is not made with natural rubber latex.1

Stabilized and buffered with glycine.1


  1. GAMMAGARD LIQUID [Immune Globulin Infusion (Human)] 10% [Prescribing Information]. Westlake Village, CA: Baxalta US Inc.
  2. The Marketing Research Bureau. The Plasma Proteins Market in the United States 2015. Orange, CT: Marketing Research Bureau, Inc; 2016.
  3. Data on file. Baxter Healthcare Corporation. 2011.


Call MyIgSource at 1-855-250-5111.



With MyIgSource, you are not alone.


  • Educational Resources and Tools
  • Patient and Nurse Advocates
  • Insurance & Financial Support for Eligible Patients

Please expand for Indication and Detailed Important Safety Information.

Selected Important Safety Information about GAMMAGARD LIQUID
  • GAMMAGARD LIQUID can cause decreased kidney function or kidney failure, blood clots in the heart, brain, lungs or elsewhere in the body. Call your healthcare professional or go to your emergency department right away if you have: Reduced urination, sudden weight gain, or swelling in your legs. These could be signs of a kidney problem. Pain, swelling, warmth, redness, or a lump in your legs or arms. These could be signs of a blood clot.
  • Do not take GAMMAGARD LIQUID if you have a known history of a severe allergic reaction to IgG or other blood products.